United States · Series A startup

Who invested in Luna Diabetes

One round we have observed, with the 2 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Healthcare

Funding summaryUpdated 27 Oct 2026

$24Mraised across 1 round since 2025, from 3 sources

Latest round
Series A, $24MAug 2025
Led by
Vensana Capital
Investors
2 (1 led)
See who backed them

The rounds

  1. Aug 2025
    Series A$24M

    Reported by Firms' own news pages and 2 others

Everyone who backed them

Vensana CapitalVC firm1round, led 1
Winklevoss CapitalFamily office1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

These 2 firms list Luna Diabetes as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.

Interlock CapitalVC firmPer its own site
Rising Tide PartnersVC firmPer its own site

Quick answers about Luna Diabetes

Who invested in Luna Diabetes?

Luna Diabetes's investors include Vensana Capital and Winklevoss Capital. Vensana Capital led its latest round.

How much has Luna Diabetes raised?

Luna Diabetes has raised $24M across 1 round since 2025.

When did Luna Diabetes last raise?

Luna Diabetes's most recent round was a Series A of $24M in Aug 2025, led by Vensana Capital.

What was Luna Diabetes's biggest round?

Its most recent round, $24M in Aug 2025, is also its largest on record.

Who backed Luna Diabetes first?

Luna Diabetes's first round on record, in Aug 2025, was backed by Vensana Capital and Winklevoss Capital.

What stage is Luna Diabetes at?

Luna Diabetes's latest named round is a Series A, in Aug 2025.

Where is Luna Diabetes based?

Luna Diabetes is based in the United States.

Who led Luna Diabetes's rounds?

Vensana Capital led the Series A in 2025.

Companies like Luna Diabetes

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.